RESEARCH TRIANGLE PARK, N.C. & TORONTO–(BUSINESS WIRE)–Analytics
4 Life, a digital health company dedicated to improving existing
diagnostic pathways, today announced that it has further strengthened
its leadership team with the appointment of William Revelos as Vice
President and General Counsel. In his role, Mr. Revelos will be
instrumental in helping Analytics 4 Life grow its clinical program and
build its patent portfolio. The Company recently announced
a research expansion of its CorVista® imaging platform into pulmonary
hypertension and that it will be running four clinical studies this year.
“I have had the pleasure of working with Bill for the past ten years,”
said Don Crawford, chief executive officer at Analytics 4 Life. “Given
his significant patent law expertise and deep understanding of the
medical device field, Bill will add valuable perspective as we seek to
advance our program. This is an exciting time for Bill and Analytics 4
Life as we continue to expand our operations.”
For nearly ten years, Mr. Revelos has served as principal of Insight
Legal Services. In this role, he provided intellectual property
counseling and acted as outside in-house counsel to companies in the
medical device sector. Prior to Insight Legal Services, Mr. Revelos was
General Counsel at Zeltiq Aesthetics (acquired by Allergan), Senior
Patent Counsel at Boston Scientific, and General Counsel at TriVascular
(acquired by Boston Scientific).
Mr. Revelos holds a B.S.E.M. from the U.S. Air Force Academy, an
M.S.M.E. from the University of Dayton, and a J.D. from The George
Washington University Law School.
CorVista is a non-invasive medical imaging system that is designed to
acquire and process patient data and display results in a report
accessible via a secure web portal. The system scans signals emitted by
the body without radiation, exercise, or pharmacologic stress and
wirelessly transmits the signal package to the cloud for processing and
report generation. Physicians can interpret and use the results as part
of an assessment of their patient. CorVista is an investigational device
limited by federal law to investigational use. CorVista is not available
for commercial distribution.
About Analytics 4 Life®
Analytics 4 Life is pioneering digital health using artificial
intelligence to develop a completely new form of medical imaging. With
an initial focus on coronary artery disease and pulmonary hypertension,
Analytics 4 Life is advancing a novel, radiation-free, and exercise-free
cardiac imaging technology aimed at improving existing care pathways.
Analytics 4 Life is based in Toronto with U.S. headquarters in Research
Triangle Park, NC. For more information, visit www.analytics4life.com.